JPS61114734A - Method for immobilizing physiologically active substance and fiber therefor - Google Patents
Method for immobilizing physiologically active substance and fiber thereforInfo
- Publication number
- JPS61114734A JPS61114734A JP59234897A JP23489784A JPS61114734A JP S61114734 A JPS61114734 A JP S61114734A JP 59234897 A JP59234897 A JP 59234897A JP 23489784 A JP23489784 A JP 23489784A JP S61114734 A JPS61114734 A JP S61114734A
- Authority
- JP
- Japan
- Prior art keywords
- physiologically active
- active substance
- molded product
- polymer molded
- vinyl polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- External Artificial Organs (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は不溶性ビニル重合体成形品に生理活性物質を固
定化する方法および該固定化繊維に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for immobilizing a physiologically active substance on an insoluble vinyl polymer molded article and to the immobilized fiber.
(従来技術〕
不溶性担体に酵素、微生物、その他生理活性物質を化学
的に結合せしめた材料がバイオリアクター、電極、血液
浄化用アフイニテイ吸着剤とじて工学、理学、医療の分
野で応用または研究されている。用いられる不溶性担体
としてはアガロース系、架橋デキストラン系、架橋ポリ
アクリルアミド系などの親水性支持体や、多孔性シリカ
ビーズなどの粒状担体あるいは本発明者らがすでに提案
しているような(特願昭58−112695>$1雑状
担体などが挙げられる。(Prior art) Materials in which enzymes, microorganisms, and other physiologically active substances are chemically bonded to insoluble carriers have been applied or researched in the fields of engineering, science, and medicine as bioreactors, electrodes, and affinity adsorbents for blood purification. Examples of insoluble carriers that can be used include hydrophilic supports such as agarose-based, cross-linked dextran-based, and cross-linked polyacrylamide-based supports, granular supports such as porous silica beads, and granular supports such as those already proposed by the present inventors (particularly Examples include miscellaneous carriers.
このような不溶性担体に例えば生理活性物質を化学的に
固定化する方法においては、固−液不均−系での反応で
あるため、反応速度が非常に遅く容易に固定化密度を大
きくできないという欠点があった。さらにアフイニテイ
吸着剤等においては目的物質と選択的あるいは特異的に
相互作用するりガントが高密度で固定化されていること
が望ましいので、このような材料の開発上問題点を有し
ていた。In the method of chemically immobilizing, for example, a physiologically active substance on such an insoluble carrier, the reaction rate is very slow and the immobilization density cannot be easily increased because the reaction is in a solid-liquid heterogeneous system. There were drawbacks. Furthermore, in affinity adsorbents, etc., it is desirable that Gantts that selectively or specifically interact with the target substance be immobilized at high density, which has caused problems in the development of such materials.
不溶性ビニル重合体成形品に生理活性物質を高密度に固
定化すること。Immobilizing physiologically active substances in insoluble vinyl polymer molded articles at high density.
(問題点を解決するための手段)
本発明は
(1)不溶性ビニル重合体成形品に生理活性物質を固定
化する方法において、該成形品を膨潤し得る有機溶媒の
存在下で固定化させることを特徴とする生理活性物質の
固定化方法。(Means for Solving the Problems) The present invention provides (1) a method for immobilizing a physiologically active substance on an insoluble vinyl polymer molded article, in which the molded article is immobilized in the presence of an organic solvent capable of swelling; A method for immobilizing a physiologically active substance, characterized by:
(2)生理活性物質がポリミキシンであり、かつその固
定化密度が繊維1g当り10IIIg以上であることを
特徴とする生理活性物質の固定化繊維、に関するもので
ある。(2) The present invention relates to a bioactive substance-immobilized fiber, characterized in that the bioactive substance is polymyxin, and the immobilization density is 10IIIg or more per gram of fiber.
不溶性ビニル重合体の例としては、スチレン、塩化ビニ
ル、アクリル酸アミド、アクリロニトリル、無水マレイ
ン酸、メタクリル酸エステルなどで代表されるモノビニ
ル化合物の単独重合体または共重合体、または、ジビニ
ルベンゼンあるいはメチレンビスアクリルアミド等で代
表されるポリビニル化合物との共重合体のほか、上記モ
ノビニル化合物重合体成形品をホルムアルデヒド、クロ
ルスルホン酸などで架橋処理したものなどが挙げられる
。架橋重合体は流動性がなく、成形が困難であるので、
粒子、膜、繊維などに成形加工した後、架橋するほうが
望ましい。Examples of insoluble vinyl polymers include homopolymers or copolymers of monovinyl compounds such as styrene, vinyl chloride, acrylic amide, acrylonitrile, maleic anhydride, and methacrylic esters, or divinylbenzene or methylene bis. In addition to copolymers with polyvinyl compounds typified by acrylamide and the like, examples include those obtained by crosslinking the monovinyl compound polymer molded article with formaldehyde, chlorosulfonic acid, etc. Crosslinked polymers have no fluidity and are difficult to mold, so
It is preferable to crosslink the material after forming it into particles, membranes, fibers, etc.
ビニル重合体成形品に共有結合法により生理活性物質を
固定化するには、該重合体にα−ハロゲン化アシル基、
ハロゲン化アルキル基、イソシアン酸暴、カルボキシル
基またはカルボン酸エステル基等の官能基が重合体に直
接またはスペーサーを介して結合していることが必要で
ある。In order to immobilize a physiologically active substance on a vinyl polymer molded article by a covalent bonding method, an α-halogenated acyl group,
It is necessary that a functional group such as a halogenated alkyl group, an isocyanate group, a carboxyl group, or a carboxylic acid ester group is bonded to the polymer directly or via a spacer.
該成形品に対して膨潤性を付与する溶媒は同時に、固定
化させる生理活性物質を良く溶解することが必要であり
、例としてはジメチルスルホキシド、N、N−ジメチル
ホルムアミド、ジメチルアセトアミド、ヘキサメチルホ
スホルアミド、テトラメチルl;i!素など誘電率が1
5以上の極性非プロトン溶媒が好ましい。但しここに示
した例に限られるものではない。反応は室温で行なって
も良いが加熱しても良い。温度が高すぎるとビニル重合
体成型品から粉末の脱落が生じるので100℃以下が好
ま゛しい。本発明においては有機溶媒は成形品を膨潤し
得るだけの量が共存していれば反応溶媒は水との混合溶
媒でも良い。有■溶媒が少量成分であっても充分に膨潤
効果が発揮さ札ることもある。The solvent that imparts swelling properties to the molded article must also be able to dissolve the physiologically active substance to be immobilized. Examples include dimethyl sulfoxide, N,N-dimethylformamide, dimethylacetamide, and hexamethylphosphorol. Ruamide, tetramethyl l;i! The dielectric constant of element is 1
Polar aprotic solvents of 5 or more are preferred. However, it is not limited to the example shown here. The reaction may be carried out at room temperature or may be heated. If the temperature is too high, powder may fall off from the vinyl polymer molded product, so a temperature of 100° C. or lower is preferable. In the present invention, the reaction solvent may be a mixed solvent with water as long as the organic solvent is present in an amount sufficient to swell the molded article. Even if the solvent is a small component, the swelling effect may be sufficiently exerted.
本固定化方法により、ダラム陰性菌に対して殺菌的に作
用する抗生物質であるポリミキシンを固定化した繊維は
固定化密度が向上したことにより、本発明者らがすでに
提案したく特願昭58−112695>エンドトキシン
中和剤として優れたエンドトキシン吸’l能を発揮する
ようになったばかりでなく、予期せぬことにダラム陰性
菌であるネズミ腸チフス菌や大腸菌に対する抗菌性が改
良されたものである。By this immobilization method, the immobilization density of the fibers immobilized with polymyxin, which is an antibiotic that has a bactericidal effect on Durham-negative bacteria, has been improved. -112695> Not only does it exhibit excellent endotoxin absorption ability as an endotoxin neutralizer, but it also unexpectedly has improved antibacterial properties against Durham-negative bacteria such as Salmonella typhimurium and Escherichia coli. .
本発明でいう生理活性物質としては例えばポリミキシン
、コリスチン、ヒスタミン、ゲンタマイシン、セロトニ
ン等が挙げられるが、これらのなかでもポリミキシンは
ダラム陰性菌に対して殺菌的に作用する性質を有し、そ
の機構はダラム陰性菌の細胞壁成分のエンドトキシンと
選択的に結合し該菌を破壊する特徴を有するので、これ
を固定化した繊維は水や血液などの被処理液体中のエン
ドトキシン除去用材料として優れた性能を発揮する。Examples of physiologically active substances in the present invention include polymyxin, colistin, histamine, gentamicin, and serotonin. Among these, polymyxin has a bactericidal property against Durham-negative bacteria, and its mechanism is It has the characteristic of selectively binding to and destroying endotoxins in the cell walls of Durham-negative bacteria, so fibers with immobilized endotoxins have excellent performance as materials for removing endotoxins from liquids to be treated such as water and blood. Demonstrate.
膨潤性を付与する溶媒系で固定化することによってビニ
ル重合体成型品が膨潤し、水系で固定化する場合よりも
、より成型品の内部まで反応に関与できる。ようになり
、固定化密度が向上したものと考えられる。By immobilizing with a solvent system that imparts swelling properties, the vinyl polymer molded product swells, and the reaction can take place more deeply inside the molded product than when immobilized with an aqueous system. This is considered to be the reason why the immobilization density has improved.
さらに本発明の方法によりポリミキシンを固定化した繊
維では、従来の水系で固定化した場合に比べて、赤外ス
ベトクルのアミド−I、アミド−■のピーク位置がシフ
トしており、ざらに異なったピークが出現することから
、固定化構造が変化していると推定できる。固定化密度
の向上、固定化様式の変化が、優れたエンドトキシン吸
着能や、抗菌活性を発揮するものと推察される。Furthermore, in the fibers in which polymyxin was immobilized by the method of the present invention, the peak positions of amide-I and amide-■ in the infrared rays shifted compared to those in the case of immobilization in a conventional aqueous system, and the peak positions of amide-I and amide-■ in the infrared rays were shifted, resulting in a rough difference. From the appearance of a peak, it can be inferred that the immobilization structure has changed. It is inferred that the improvement in immobilization density and the change in immobilization mode result in excellent endotoxin adsorption ability and antibacterial activity.
実施例1
ポリプロピレン(三月″′ノーブレン”J3HCI>5
0部を島成分とし、ポリスチレン(“スタイロン”67
9)46部、ポリプロピレン(住友″′)−ブレン”W
F−727−F)4部の温合物を海成分とする海島型複
合繊維400g、N−メチロール−α−クロルアレドア
ミド560g、ニトロベンゼン3100m+、Im硫酸
202O20および、パラ小ルムアルデにド89からな
る混合液溶液中に浸し、20℃で1時間反応させた。繊
維を反応液から取り出し、0℃の氷水5α中に投じて反
応停止させたのち、水で洗浄し、次に繊維に付着してい
るニトロベンゼンをメタノールで抽出し、除去した。こ
の繊維を40℃で真空乾燥して、クロルアセトアミドメ
チル化繊維(41維A)を1qだ。Example 1 Polypropylene (Mizuki"'Noblen"J3HCI>5
0 part is the island component, polystyrene (“Styron” 67
9) 46 parts, polypropylene (Sumitomo'')-Brene''W
F-727-F) 400 g of sea-island composite fibers containing 4 parts of warm mixture as sea component, 560 g of N-methylol-α-chloraledamide, 3100 g of nitrobenzene, 202 O20 of Im sulfuric acid, and 89 to The sample was immersed in a mixed solution of 20° C. and reacted at 20° C. for 1 hour. The fibers were taken out from the reaction solution and poured into ice water 5α at 0° C. to stop the reaction, washed with water, and then nitrobenzene adhering to the fibers was extracted with methanol and removed. This fiber was vacuum dried at 40°C to yield 1 q of chloroacetamide methylated fiber (41 fiber A).
ポリミキシンB硫酸塩(含糖ファイザー社製)10gを
ジメチルスルホキシド10100Oに溶解した。この中
に繊4’lIAを359加え、かつ酸化マグネシウム5
gを加え、90℃のオイルバス中で8時間、十分に攪拌
しながら反応させた。反応終了(1、ffl?l取す出
シ、M411ヲ0.1NJ3afi95α、熱水〈90
℃>1111の順で十分に洗浄した。10 g of polymyxin B sulfate (contains sugar, manufactured by Pfizer) was dissolved in 10100O dimethyl sulfoxide. To this, 359% of fiber 4'lIA was added, and 5% of magnesium oxide was added.
g was added thereto, and the mixture was reacted in a 90°C oil bath for 8 hours with thorough stirring. Reaction completed (1, remove ffl?l, M411 0.1NJ3afi95α, hot water <90
Thorough washing was carried out in the order of ℃>1111.
このようして得られた繊維を一部取り出し、真空乾燥し
た後、6N!!酸中110℃で24時間加水分解し、ア
ミノ酸分析法により固定化量を算出したところ、当離1
gあたり157.9mOのポリミキシンBが固定化され
ていた。A portion of the fibers thus obtained was taken out and vacuum dried, followed by 6N! ! Hydrolysis was carried out in acid at 110°C for 24 hours, and the amount of immobilization was calculated by amino acid analysis.
157.9 mO of polymyxin B was immobilized per g.
比較例
ポリミキシンB硫酸塩(白糖〕1イザー社製)10gを
蒸溜水10100Oに溶解した。Comparative Example 10 g of polymyxin B sulfate (white sugar, manufactured by Iser) was dissolved in 10,100 O of distilled water.
この中に繊維Aを35g加え、かつ酸化マグネシウム5
qを加え、90℃のオイルバス中で8時間、十分に匿拌
しながら反応させた。以模実施例と同様に洗浄し、固定
化繊維を調製した。Add 35g of fiber A to this, and 5g of magnesium oxide.
q was added thereto, and the mixture was allowed to react in a 90° C. oil bath for 8 hours with sufficient stirring. Immobilized fibers were prepared by washing in the same manner as in the Example.
アミノ酸分析による固定化量はmllmgあたり1、O
mqと極めて少ない値であった。The amount of immobilization determined by amino acid analysis was 1, O per milligram.
mq, which was an extremely small value.
実施例2
実施例1で得たI!維(乾燥品)を0.5Qずつ秤量し
、減菌されたチューブ△、已にそれぞれ投入した。つい
でこの中に大腸菌菌液(28x105個)、ネズミ腸チ
フス菌菌液(7X107個)を各5ml加え窄温で12
時間振とうした。コントロールとして、菌液のみを注入
した試験管を用意し、同様に振と・うした。Example 2 I! obtained in Example 1! 0.5Q of fiber (dried product) was weighed and placed into sterilized tubes △ and △, respectively. Next, add 5 ml each of Escherichia coli bacteria solution (28 x 105 cells) and Murine typhoid bacteria solution (7 x 107 cells) to this and incubate at narrow temperature for 12 hours.
Shake for an hour. As a control, a test tube containing only the bacterial solution was prepared and shaken in the same manner.
振どう後の菌液を定量培養し、コントロールとの間でコ
ロニー数を比較し、抗菌性を判定した。After shaking, the bacterial solution was quantitatively cultured, and the number of colonies was compared with that of the control to determine antibacterial properties.
その結果、ネズミ腸チフス菌の場合には菌の減少率は9
9.7%と顕茗な抗菌活性を示すことが分った。さらに
大腸菌の場合にも97.9%の菌数の減少を示し抗菌作
用のあることが判明した。As a result, in the case of murine Salmonella typhimurium, the bacterial reduction rate was 9.
It was found that it exhibited significant antibacterial activity of 9.7%. Furthermore, in the case of Escherichia coli, the number of bacteria was reduced by 97.9%, indicating that it has an antibacterial effect.
本発明により不溶性ビニル重合体成型品に生理活性物質
を高密度に固定化することができる。さらに従来の水系
で固定化した場合とは異なった固定化構造を取ることが
可能になる。さらに本発明の方法により(aられた繊維
は単糸相互間でよく開繊し、エンドトキシンなどの吸収
剤として用いた場合には、液との接触面積が大ぎいので
吸着速度が大きくなったり、吸@量も増すという利点を
有するようになる。According to the present invention, physiologically active substances can be immobilized in an insoluble vinyl polymer molded article at high density. Furthermore, it becomes possible to have an immobilization structure different from that in the case of immobilization in a conventional aqueous system. Furthermore, the fibers produced by the method of the present invention are well spread between single filaments, and when used as an absorbent for endotoxins, etc., the contact area with the liquid is large, so the adsorption rate becomes high. It has the advantage of increasing the amount of suction.
Claims (2)
化する方法において、該成形品を膨潤し得る有機溶媒の
存在下で固定化させることを特徴とする生理活性物質の
固定化方法。(1) A method for immobilizing a physiologically active substance on an insoluble vinyl polymer molded article, the method comprising immobilizing the biologically active substance in the presence of an organic solvent that can swell the molded article.
定化密度が繊維1g当り10mg以上であることを特徴
とする生理活性物質の固定化繊維。(2) A bioactive substance-immobilized fiber, characterized in that the bioactive substance is polymyxin, and the immobilization density is 10 mg or more per 1 g of fiber.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59234897A JPS61114734A (en) | 1984-11-09 | 1984-11-09 | Method for immobilizing physiologically active substance and fiber therefor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59234897A JPS61114734A (en) | 1984-11-09 | 1984-11-09 | Method for immobilizing physiologically active substance and fiber therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61114734A true JPS61114734A (en) | 1986-06-02 |
JPH0583302B2 JPH0583302B2 (en) | 1993-11-25 |
Family
ID=16978012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59234897A Granted JPS61114734A (en) | 1984-11-09 | 1984-11-09 | Method for immobilizing physiologically active substance and fiber therefor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61114734A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5316787A (en) * | 1976-03-16 | 1978-02-16 | Ici Ltd | Specificcreactive composition |
-
1984
- 1984-11-09 JP JP59234897A patent/JPS61114734A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5316787A (en) * | 1976-03-16 | 1978-02-16 | Ici Ltd | Specificcreactive composition |
Also Published As
Publication number | Publication date |
---|---|
JPH0583302B2 (en) | 1993-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zeng et al. | Membrane chromatography: preparation and applications to protein separation | |
Zhao et al. | Blood compatible aspects of DNA-modified polysulfone membrane—protein adsorption and platelet adhesion | |
Štamberg | Bead cellulose | |
CZ65193A3 (en) | Process for producing optically active cyanhydrins | |
JPS61114734A (en) | Method for immobilizing physiologically active substance and fiber therefor | |
Uzun et al. | Poly (hydroxyethyl methacrylate) based affinity membranes for in vitro removal of anti-dsDNA antibodies from SLE plasma | |
JP2853452B2 (en) | Method for producing molded article immobilized with physiologically active substance | |
RU2174130C1 (en) | Method of modifying cellulose acetates for preparing films, membranes and biofilters | |
JPS6229978A (en) | Carrier for immobilizing physiologically active substance | |
JP3733657B2 (en) | Material for removing or detoxifying polypeptide antibiotics | |
JP3890625B2 (en) | Super antigen adsorption material | |
JP2002327001A (en) | Method of selective adsorption for saccharide, particle, compound and cell adhesion factor and method for controlling cancer metastasis | |
JPH02311500A (en) | Production of immobilized low molecular protein a | |
Yoshida et al. | Immobilization of cellulase in the swollen microsphere by radiation polymerization | |
JPH0757760B2 (en) | Immobilization method for biological substances | |
CN108579698B (en) | Preparation of endotoxin specific adsorption membrane and application of membrane in assisted reproduction field | |
JP2613153B2 (en) | Method for producing carrier for immobilizing microorganisms | |
JP2613154B2 (en) | Method for producing carrier for immobilizing microorganisms | |
JP2660649B2 (en) | Method for producing enzyme-immobilizing carrier | |
JPH01242105A (en) | Material for removing endotoxin | |
JPH0585158B2 (en) | ||
SU755296A1 (en) | Method of producing activated substrate for immobilisation of biologically active substances | |
JP2656108B2 (en) | Immobilized enzyme and method for producing the same | |
JPS61135674A (en) | Removal of endotoxin from immobilized polymixing molded product | |
JPH07151758A (en) | Method for immobilizing antibiotic by photochemical reaction on carrier, and lps, microorganism catching method, and determining method using the carrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |